LOS ANGELES--(BUSINESS WIRE)--Auriga Laboratories, Inc. (OTCBB: ARGA), a specialty pharmaceutical company with products for the treatment of Xerostomia, dermatological conditions, and acute respiratory diseases, announced today that Thomas Weisel – Discovery Research has initiated coverage of the Company with an “Outperform” rating and a 12-month price target of $2.00.
